Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oncology Reimbursement Solutions (ORS) is a specialized consulting and technology firm that provides comprehensive reimbursement support and financial navigation services for oncology practices and pharmaceutical manufacturers. The company focuses on optimizing the revenue cycle, ensuring accurate coding and billing for complex cancer therapies, and facilitating patient access to medications. Following its acquisition by AmerisourceBergen (now Cencora), ORS operates as part of ION Solutions, leveraging data-driven insights to help healthcare providers manage the financial complexities of oncology care. Their services include payer policy analysis, claim dispute resolution, and strategic market access consulting.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oncology Reimbursement Solutions.